Patents by Inventor Michel-Robert Popoff

Michel-Robert Popoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predictive value of -specific immune response for recurrence and disease outcome
    Patent number: 10890583
    Abstract: The present invention relates to the field of Clostridium difficile infections. Methods of diagnosing, treating and preventing Clostridium difficile-associated disease and recurrent CDAD are disclosed herein.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: January 12, 2021
    Assignees: INSTITUT PASTEUR, UNIVERSITE PARIS-SUD, CENTRE HOSPITALIER DE VERSAILLES, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
    Inventors: Marie-Lise Gougeon, Alban Le Monnier, Anne Collignon, Michel Robert Popoff
  • PREDICTIVE VALUE OF CLOSTRIDIUM DIFFICILE-SPECIFIC IMMUNE RESPONSE FOR RECURRENCE AND DISEASE OUTCOME
    Publication number: 20170212113
    Abstract: The present invention relates to the field of Clostridium difficile infections. Methods of diagnosing, treating and preventing Clostridium difficile-associated disease and recurrent CDAD are disclosed herein.
    Type: Application
    Filed: April 1, 2015
    Publication date: July 27, 2017
    Inventors: Marie-Lise GOUGEON, Alban LE MONNIER, Anne COLLIGNON, Michel Robert POPOFF
  • toxin, and process for the preparation of immunogenic composition
    Patent number: 8147841
    Abstract: The present invention relates to the field of bacterial toxic proteins, in particular toxins from Clostridium or other pathogenic organisms using, for example, promoter nucleic acids to control expression of polypeptides such as bacterial toxins.
    Type: Grant
    Filed: June 21, 2006
    Date of Patent: April 3, 2012
    Assignee: Institut Pasteur
    Inventors: Maryse Gibert, Michel-Robert Popoff
  • Clostridium toxin, and process for the preparation of immunogenic composition
    Publication number: 20110223186
    Abstract: The present invention relates to the field of bacterial toxic proteins, in particular toxins from Clostridium or other pathogenic organisms using, for example, promoter nucleic acids to control expression of polypeptides such as bacterial toxins.
    Type: Application
    Filed: June 21, 2006
    Publication date: September 15, 2011
    Applicant: INSTITUT PASTEUR
    Inventors: Maryse Gibert, Michel-Robert Popoff
  • Clostridium toxin, and process for the preparation of immunogenic composition
    Publication number: 20080089904
    Abstract: The present invention relates to the field of bacterial toxic proteins, in particular toxins from Clostridium or other pathogenic organisms using, for example, promoter nucleic acids to control expression of polypeptides such as bacterial toxins.
    Type: Application
    Filed: June 21, 2006
    Publication date: April 17, 2008
    Applicant: INSTITUT PASTEUR
    Inventors: Maryse Gibert, Michel-Robert Popoff
  • Clostridium perfringens beta-2 toxin signal sequence, promoter and recombinant prokarote host cells comprising them
    Patent number: 7144998
    Abstract: Recombinant polypeptides are prepared using novel nucleic acids with transcription promoter activity. The recombinant cells containing said nucleic acids are described. A novel method for preparing antigens or antigen fragments, in particular bacterial toxins, preferably Clostridum toxins, for preparing immunogenic and/or vaccine compositions is also described.
    Type: Grant
    Filed: March 20, 2000
    Date of Patent: December 5, 2006
    Assignee: Institut Pasteur
    Inventors: Maryse Gibert, Michel-Robert Popoff